BioSpace News Archive

Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that Dr. Christian Itin, chairman and chief executive officer, will present at the Cowen 40th Annual Health Care Conference in Boston on Wednesday, March 4, 2020 at 10.00 am ET.

MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet medical needs in severe burn and wound management, today announced financial results for the fourth quarter and full-year ended December 31, 2019.

Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2019 results.

Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN.TA), a leading company in leveraging computational biology to design novel products for life-science-based industries including: human health, agriculture and industrial applications, announces today that Eran Kosover, CEO of AgPlenus, Evogene’s subsidiary designing effective and sustainable crop protection products, will attend in the BofA 2020 Global Agriculture and Materials Conference

Results of a new clinical study show that Bergacyn®, a patented, clean-label botanical extract blend for digestive and metabolic support, has beneficial effects in reducing liver steatosis (excessive fat in the liver), inflammation, and oxidative stress in type 2 diabetes

Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced the publication of nonclinical data on the mechanism of action of nesolicaftor (PTI-428).

Syndax Pharmaceuticals, Inc. (“Syndax,” the “Company” or “we”) (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, announced today that it will release its fourth quarter and year-end 2019 financial results on Tuesday, March 3, after the close of the U.S. financial markets

Oncologie, Inc., a clinical-stage biopharmaceutical company developing innovative oncology treatments targeting the tumor microenvironment (TME), announced today that it has entered into a collaboration agreement with Moffitt Cancer Center.

With the release of Ansys® RaptorH™, Ansys (NASDAQ: ANSS) will empower engineers to accelerate and improve 5G, three-dimensional integrated circuit (3D-IC) and radio-frequency integrated circuit design workflows for innovations like smart devices, antenna arrays and data storage systems.

Bit Bio announces agreement with Abcam, a global innovator in life science reagents and tools, to make Bit Bio’s iPSC derived functional human cells widely available to the global life science community.